BVS Q1 2023 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$119M+1.5% YoY

Gross Profit

$74M62.1% margin

Operating Income

-$92M-77.3% margin

Net Income

-$139M-116.9% margin

EPS (Diluted)

$-2.24

QoQ Revenue Growth

-5.4%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$1M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$887M

Total Liabilities

$647M

Stockholders' Equity

$189M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$119M	$117M	+1.5%
Gross Profit	$74M	$76M	-2.4%
Operating Income	-$92M	-$21M	-329.2%
Net Income	-$139M	-$11M	-1133.9%

Geographic Segments

UNITED STATES

$208M87%

Non-US

$30M13%